LRMR   $6.16  0.49% Market Closed After Close 6.16 0.0

Larimar Therapeutics Inc
Total Cash 203.71M
totalCashPerShare 3.193
EBITDA -73.44M
Total Debt 5.36M
quickRatio 12.567
currentRatio 13.095
Total Revenue
debtToEquity 2.703
Revenue/Share
ROA -0.28547
ROE -0.445
grossProfits
freeCashflow -35.22M
operatingCashflow -58.29M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 271.27M
forwardPE -5.0683227
floatShares 31.93M
sharesOutstanding 63.81M
sharesShort 3.71M
sharesShortPriorMonth 3.33M
dateShortInterest
sharesPercentSharesOut 0.06%
heldPercentInsiders 0.01%
heldPercentInstitutions 1.08%
Short Ratio help_outline 4.53%
shortPercentOfFloat 0.09%
impliedSharesOutstanding
bookValue 3.109
Price To Book help_outline 2.62
earningsQuarterlyGrowth
netIncomeToCommon -64.77M
trailingEps -1.15%
forwardEps -1.61%
enterpriseToEbitda -3.69
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.32 4Q 2024
institutionsCount 148
lastUpdated Nov. 7, 2024, 3:15 a.m.